We are Galapagos UK, a pioneering biotechnology company, with the ambition of becoming a leading biopharmaceutical company, focused on making a difference to people with inflammatory and fibrotic diseases. With our pioneering spirit we aim to make a lasting, positive contribution to society by delivering breakthrough medicines we have discovered to patients. We believe in ‘we’ not ‘us’ and together with the inflammation healthcare community, we will continue to push the possibilities of our work to tackle chronic disease and improve the lives of patients. Our motto is simple: We discover. We dare. We care.